LD 697 directs Maine's Prescription Drug Affordability Board to set annual spending targets for prescription drugs purchased by state and local government health plans (excluding MaineCare), using a formula based on a 10-year average of medical care costs plus inflation, minus savings. The board must assess cost-reduction strategies, including reference-based pricing - which aligns drug prices with those in other regions - and establish a 12-member advisory council with representatives from state agencies, labor unions, and consumer groups to advise on setting targets and methods. The board will also identify public payors (state, county, and municipal health plans) likely to exceed the spending targets.
LD 784 requires Maine health insurance plans to cover specific preventive screenings for first responders (including firefighters, police officers, EMTs, and emergency communications personnel) without denying coverage, requiring prior authorization (except to verify first responder status or for screenings by designated providers), or charging out-of-pocket costs. The screenings include cancer tests linked to job risks, blood tests, age-independent cancer screenings, and tests for inflammation or nutritional deficiencies. This law applies to all health insurance policies issued or renewed on or after January 1, 2027, ensuring first responders can access these preventive services without financial or administrative barriers.
LD 1154 requires healthcare providers to inform women seeking an abortion for a fetus diagnosed with a lethal fetal anomaly (a condition likely to cause the baby's death within three months after birth) about perinatal hospice services as part of the informed consent process. Providers must discuss these services in person at least 24 hours before the procedure and provide a written list of available perinatal hospice providers, which the state will maintain. If the woman declines hospice services and chooses to proceed with the abortion, she must sign a written certification confirming her decision. This requirement does not apply in cases of medical emergencies or for abortions related to ectopic pregnancy or spontaneous miscarriage.
LD 1007 requires healthcare professionals in Maine to provide specific information during informed consent for drug-induced abortions. It mandates that providers inform patients about the potential for reversal if they change their mind (noting time sensitivity), and that initial studies suggest no increased maternal mortality or birth defect risks from reversal. Providers must also give patients a written statement with a website and helpline number (to be updated annually by the Department of Health) for information on abortion pill reversal services. This bill directly affects women seeking drug-induced abortions and their healthcare providers in Maine.
LD 253 repeals Maine Revised Statutes, Title 22, section 3196, which previously required the MaineCare program (Maine's Medicaid program) to cover abortion services for enrollees. This bill removes the mandate that the Department of Health and Human Services fund abortion services, including state funding when federal Medicaid does not cover them. As a result, MaineCare would no longer be required to cover abortion services for its members. The bill directly affects MaineCare enrollees who previously had access to this coverage under the repealed law.
LD 682 requires healthcare providers to report abortion procedures to Maine's Department of Health and Human Services, including patient demographics like race, marital status, and education level, as specified by national public health standards. It changes the standard for abortions after fetal viability to allow them only when medically necessary to preserve the mother's life or health, or when a fetus has a "lethal fetal anomaly" (a condition likely to cause the baby's death within three months after birth). The bill reinstates criminal penalties for unlicensed individuals performing abortions or assisting unlicensed providers, and clarifies that only licensed physicians, physician assistants, or advanced practice nurses may perform abortions. These changes directly affect abortion providers, patients receiving care, and state health data collection.
LD 1712 amends Maine's Paid Family and Medical Leave program to adjust requirements for employees and employers. It requires employees to give reasonable notice before taking leave and allows employers to deny leave based on specific, defined hardships (such as having fewer than 15 employees, a summer labor shortage, or more than 25% of staff already on leave), without review of such decisions. The bill also revises benefit calculations to replace 65% of average weekly wage (with 90% replacement for wages up to 50% of the state average and 66% for higher wages), shortens application deadlines for benefits (with waivers for good cause), and modifies premium payments so employers deduct 50% of the cost from employee wages while covering the remaining 50%.
LD 544 exempts sales of cannabis for medical use from Maine's sales tax, creating tax parity with prescription medicines. The bill amends Maine's tax code to include medical cannabis sales (after January 1, 2026) under the existing exemption for prescription medicines sold by doctors. It directly affects patients certified for medical cannabis use under Maine's Medical Use of Cannabis Act and providers selling to them. This policy change removes a sales tax burden currently applied to medical cannabis, aligning its tax treatment with other prescribed medicines. The exemption applies only to cannabis sold with a medical provider's certification, not recreational sales.
This bill repeals Maine's mandatory paid family and medical leave program, making participation voluntary instead. It limits the program to employers with 50 or more employees and requires the Department of Labor to refund all contributions made under the previous mandatory system to both employers and employees by June 2026. Unappropriated funds from the leave program must be transferred to the state's general fund by June 30, 2026. The changes take effect retroactively to October 25, 2023.
This bill exempts agricultural employers and employees from Maine's Paid Family and Medical Leave Benefits Program, directly affecting those working in agriculture as defined by state and federal law. It requires the Department of Labor to refund all contributions paid by agricultural employers and self-employed individuals to the program, including any premiums deducted from employee wages that must be returned to workers. The refunds apply retroactively to October 25, 2023, when contributions began. The legislation aims to halt economic harm to the agricultural sector by eliminating these financial obligations.
